Avidity Partners Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
|
|||||
|
2025
Q1 | $11.4M | Sell |
|
|||||
|
2024
Q4 | $19.8M | Sell |
|
|||||
|
2024
Q3 | $47.3M | Sell |
|
|||||
|
2024
Q2 | $68.5M | Buy |
|
|||||
|
2024
Q1 | $57.4M | Sell |
|
|||||
|
2023
Q4 | $85.4M | Buy |
|
|||||
|
2023
Q3 | $41M | Sell |
|
|||||
|
2023
Q2 | $60.1M | Sell |
|
|||||
|
2023
Q1 | $81.6M | Sell |
|
|||||
|
2022
Q4 | $149M | Buy |
|
|||||
|
2022
Q3 | $134M | Buy |
|
|||||
|
2022
Q2 | $105M | Buy |
|
|||||
|
2022
Q1 | $83.8M | Hold |
|
|||||
|
2021
Q4 | $106M | Hold |
|
|||||
|
2021
Q3 | $92.2M | Buy |
|
|||||
|
2021
Q2 | $79.2M | Buy |
|
|||||
|
2021
Q1 | $86M | Buy |
|
|||||
|
2020
Q4 | $73.6M | Buy |
|
|||||
|
2020
Q3 | $27.4M | Buy |
|
|||||
|
2020
Q2 | $22.6M | Buy |
|